171 related articles for article (PubMed ID: 35017718)
1. Comparable anti-CMV responses of transplant donor and third-party CMV-specific T cells for treatment of CMV infection after allogeneic stem cell transplantation.
Pei XY; Liu XF; Zhao XY; Lv M; Mo XD; Chang YJ; Shang QN; Sun YQ; Chen YH; Xu LP; Wang Y; Zhang XH; Liu KY; Huang XJ
Cell Mol Immunol; 2022 Apr; 19(4):482-491. PubMed ID: 35017718
[TBL] [Abstract][Full Text] [Related]
2. Adoptive therapy with cytomegalovirus-specific cytotoxic T lymphocytes for refractory cytomegalovirus DNAemia and disease after allogeneic haematopoietic stem cell transplantation.
Jiang Z; Fan Z; Zhang T; Lin R; Xu H; Xu N; Huang F; Chi P; Ou X; Wang Z; Liu H; Zhao K; Jiang L; Yu S; Sun J; Liu Q; Xuan L
Br J Haematol; 2024 Apr; 204(4):1393-1401. PubMed ID: 38168845
[TBL] [Abstract][Full Text] [Related]
3. [Cytomegalovirus specific cytotoxic T lymphocytes for treatment of refractory cytomegalovirus infection in patients following allogeneic hematopoietic stem cell transplantation].
Xu Z; Huang X; Sun Y; Wang F; Yan C; Zhang X; Han W; Chen Y; Wang J; Chen H; Wang Y; Zhang Y; Liu K; Xu L
Zhonghua Nei Ke Za Zhi; 2015 Feb; 54(2):101-5. PubMed ID: 25907838
[TBL] [Abstract][Full Text] [Related]
4. Transfer of minimally manipulated CMV-specific T cells from stem cell or third-party donors to treat CMV infection after allo-HSCT.
Neuenhahn M; Albrecht J; Odendahl M; Schlott F; Dössinger G; Schiemann M; Lakshmipathi S; Martin K; Bunjes D; Harsdorf S; Weissinger EM; Menzel H; Verbeek M; Uharek L; Kröger N; Wagner E; Kobbe G; Schroeder T; Schmitt M; Held G; Herr W; Germeroth L; Bonig H; Tonn T; Einsele H; Busch DH; Grigoleit GU
Leukemia; 2017 Oct; 31(10):2161-2171. PubMed ID: 28090089
[TBL] [Abstract][Full Text] [Related]
5. Adoptive therapy with CMV-specific cytotoxic T lymphocytes depends on baseline CD4+ immunity to mediate durable responses.
Fabrizio VA; Rodriguez-Sanchez MI; Mauguen A; Dahi PB; Doubrovina E; O'Reilly RJ; Prockop SE
Blood Adv; 2021 Jan; 5(2):496-503. PubMed ID: 33496746
[TBL] [Abstract][Full Text] [Related]
6. Possible Impact of Cytomegalovirus-Specific CD8
Ogonek J; Varanasi P; Luther S; Schweier P; Kühnau W; Göhring G; Dammann E; Stadler M; Ganser A; Borchers S; Koehl U; Weissinger EM; Hambach L
Biol Blood Marrow Transplant; 2017 Jul; 23(7):1046-1053. PubMed ID: 28344058
[TBL] [Abstract][Full Text] [Related]
7. Characterization of High-Avidity Cytomegalovirus-Specific T Cells with Differential Tetramer Binding Coappearing after Allogeneic Stem Cell Transplantation.
Ogonek J; Verma K; Schultze-Florey C; Varanasi P; Luther S; Schweier P; Kühnau W; Göhring G; Dammann E; Stadler M; Ganser A; Koehl U; Koenecke C; Weissinger EM; Hambach L
J Immunol; 2017 Jul; 199(2):792-805. PubMed ID: 28630092
[TBL] [Abstract][Full Text] [Related]
8. Donor CMV-specific cytotoxic T lymphocytes successfully treated drug-resistant cytomegalovirus encephalitis after allogeneic hematopoietic stem cell transplantation.
Ke P; Bao X; Zhou J; Li X; Zhuang J; He X; Wu D; Zhang X; Ma X
Hematology; 2020 Dec; 25(1):43-47. PubMed ID: 31906810
[No Abstract] [Full Text] [Related]
9. First-line Therapy With Donor-derived Human Cytomegalovirus (HCMV)-specific T Cells Reduces Persistent HCMV Infection by Promoting Antiviral Immunity After Allogenic Stem Cell Transplantation.
Zhao XY; Pei XY; Chang YJ; Yu XX; Xu LP; Wang Y; Zhang XH; Liu KY; Huang XJ
Clin Infect Dis; 2020 Mar; 70(7):1429-1437. PubMed ID: 31067570
[TBL] [Abstract][Full Text] [Related]
10. Adoptive therapy with cytomegalovirus-specific T cells for cytomegalovirus infection after haploidentical stem cell transplantation and factors affecting efficacy.
Pei XY; Zhao XY; Liu XF; Mo XD; Lv M; Xu LP; Wang Y; Chang YJ; Zhang XH; Liu KY; Huang XJ
Am J Hematol; 2022 Jun; 97(6):762-769. PubMed ID: 35293011
[TBL] [Abstract][Full Text] [Related]
11. Adoptive T-cell immunotherapy from third-party donors: characterization of donors and set up of a T-cell donor registry.
Eiz-Vesper B; Maecker-Kolhoff B; Blasczyk R
Front Immunol; 2012; 3():410. PubMed ID: 23372567
[TBL] [Abstract][Full Text] [Related]
12. Expansion of cytomegalovirus pp65 and IE-1 specific cytotoxic T lymphocytes for cytomegalovirus-specific immunotherapy following allogeneic stem cell transplantation.
Bao L; Dunham K; Stamer M; Mulieri KM; Lucas KG
Biol Blood Marrow Transplant; 2008 Oct; 14(10):1156-1162. PubMed ID: 18804046
[TBL] [Abstract][Full Text] [Related]
13. Protective immunity transferred by infusion of cytomegalovirus-specific CD8(+) T cells within donor grafts: its associations with cytomegalovirus reactivation following unmanipulated allogeneic hematopoietic stem cell transplantation.
Luo XH; Huang XJ; Liu KY; Xu LP; Liu DH
Biol Blood Marrow Transplant; 2010 Jul; 16(7):994-1004. PubMed ID: 20167279
[TBL] [Abstract][Full Text] [Related]
14. Persistence of recipient-derived as well as donor-derived clones of cytomegalovirus pp65-specific cytotoxic T cells long after allogeneic hematopoietic stem cell transplantation.
Terasako-Saito K; Nakasone H; Tanaka Y; Yamazaki R; Sato M; Sakamoto K; Ishihara Y; Kawamura K; Akahoshi Y; Hayakawa J; Wada H; Harada N; Nakano H; Kameda K; Ugai T; Yamasaki R; Ashizawa M; Kimura SI; Kikuchi M; Tanihara A; Kanda J; Kako S; Nishida J; Kanda Y
Transpl Infect Dis; 2014 Dec; 16(6):930-40. PubMed ID: 25430567
[TBL] [Abstract][Full Text] [Related]
15. Treatment of a patient with severe cytomegalovirus (CMV) infection after haploidentical stem cell transplantation with donor derived CMV specific T cells.
Ingels J; De Smet S; Heyns K; Lootens N; Segaert J; Taghon T; Leclercq G; Vermaelen K; Willems E; Baudoux E; Kerre T; Baron F; Vandekerckhove B
Acta Clin Belg; 2021 Dec; 76(6):482-486. PubMed ID: 32285755
[No Abstract] [Full Text] [Related]
16. Adoptive immunotherapy with CMV-specific cytotoxic T lymphocytes for stem cell transplant patients with refractory CMV infections.
Bao L; Cowan MJ; Dunham K; Horn B; McGuirk J; Gilman A; Lucas KG
J Immunother; 2012 Apr; 35(3):293-8. PubMed ID: 22421947
[TBL] [Abstract][Full Text] [Related]
17. Isolation of highly suppressive CD25+FoxP3+ T regulatory cells from G-CSF-mobilized donors with retention of cytotoxic anti-viral CTLs: application for multi-functional immunotherapy post stem cell transplantation.
Samuel ER; Beloki L; Newton K; Mackinnon S; Lowdell MW
PLoS One; 2014; 9(1):e85911. PubMed ID: 24465783
[TBL] [Abstract][Full Text] [Related]
18. Direct visualization of cytomegalovirus-specific T-cell reconstitution after allogeneic stem cell transplantation.
Cwynarski K; Ainsworth J; Cobbold M; Wagner S; Mahendra P; Apperley J; Goldman J; Craddock C; Moss PA
Blood; 2001 Mar; 97(5):1232-40. PubMed ID: 11222365
[TBL] [Abstract][Full Text] [Related]
19. Single-cell T-cell receptor-β analysis of HLA-A*2402-restricted CMV- pp65-specific cytotoxic T-cells in allogeneic hematopoietic SCT.
Nakasone H; Tanaka Y; Yamazaki R; Terasako K; Sato M; Sakamoto K; Yamasaki R; Wada H; Ishihara Y; Kawamura K; Machishima T; Ashizawa M; Kimura SI; Kikuchi M; Tanihara A; Kanda J; Kako S; Nishida J; Kanda Y
Bone Marrow Transplant; 2014 Jan; 49(1):87-94. PubMed ID: 23933763
[TBL] [Abstract][Full Text] [Related]
20. Detailed analysis of cytomegalovirus (CMV)-specific T cells expanded for adoptive immunotherapy of CMV infection following allogeneic stem cell transplantation for malignant disease.
Hobeika A; Osada T; Serra D; Peplinski S; Hanson K; Tanaka Y; Niedzwiecki D; Chao N; Rizzieri D; Lyerly H; Clay T; Morse M
Cytotherapy; 2008; 10(3):289-302. PubMed ID: 18418774
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
